Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Novel Nitroxyl (HNO) Prodrugs And Biomedical Applications Thereof

  • Read more about Novel Nitroxyl (HNO) Prodrugs And Biomedical Applications Thereof
US Application 61/315,604
Filed on 2010-03-19

Development Of A Vaccine Composed Of CpG Oligonucleolides Conjugated To Apoptotic Tumor Cells To Treat Cancer.

  • Read more about Development Of A Vaccine Composed Of CpG Oligonucleolides Conjugated To Apoptotic Tumor Cells To Treat Cancer.
US Application 61/309,802
Filed on 2010-03-02

Diagnosis and Treatment of Cancer Through NUAK2 Assessment and Modulation

  • Read more about Diagnosis and Treatment of Cancer Through NUAK2 Assessment and Modulation
US Application 61/321,136
Filed on 2010-04-05

Nitric Oxide-based Cancer Therapeutic Agents For Lung Cancers With Elevated Levels Of Reactive Oxygen Species (ROS) And/or Low Levels Of Antioxidant Defense/DNA Repair
mechanisms.

  • Read more about Nitric Oxide-based Cancer Therapeutic Agents For Lung Cancers With Elevated Levels Of Reactive Oxygen Species (ROS) And/or Low Levels Of Antioxidant Defense/DNA Repair mechanisms.
US Application 61/261,175
Filed on 2009-11-13

Programmed Death Ligand-1 (PD-L1) Immune Modulation Gene Therapy

  • Read more about Programmed Death Ligand-1 (PD-L1) Immune Modulation Gene Therapy
US Application 61/261,081
Filed on 2009-11-13

Methods, Compositions And Kits For MiRNA In Situ Hybridization Detection, Quantification And Identification Of Cancer Biomarkers And Companion Diagnostic Assay For Cancer Therapy

  • Read more about Methods, Compositions And Kits For MiRNA In Situ Hybridization Detection, Quantification And Identification Of Cancer Biomarkers And Companion Diagnostic Assay For Cancer Therapy
US Application 61/253,617
Filed on 2009-10-21

Assays For Soluble IL-15 Receptor Alpha

  • Read more about Assays For Soluble IL-15 Receptor Alpha
US Application 61/242,595
Filed on 2009-09-15

Method for Predicting of Patient Immune Responses Outcome To Treatment With Keyhole Limpet Hemocyanin

  • Read more about Method for Predicting of Patient Immune Responses Outcome To Treatment With Keyhole Limpet Hemocyanin
US Application 61/243,849
Filed on 2009-09-18

A Method For Generating A Beaded Protein Microarray

  • Read more about A Method For Generating A Beaded Protein Microarray
US Application 61/260,876
Filed on 2009-11-13

Improved Pseudomonas Exotoxin A With Reduced Immunogenicity

  • Read more about Improved Pseudomonas Exotoxin A With Reduced Immunogenicity
US Application 61/241,620
Filed on 2009-09-11

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 119
  • Page 120
  • Page 121
  • Page 122
  • Page 123
  • Page 124
  • Page 125
  • Page 126
  • Page 127
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health